A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Lung Cancer|Bronchial Cancer|Non Small Cell Lung Cancer|Small Cell Lung Cancer|Sarcoma|Colorectal Cancer|Gastric Cancer|Liver Cancer|Breast Cancer|Pancreatic Cancer|Head and Neck Cancer|Ovarian Cancer
Interventions: DRUG: Recombinant oncolytic herpes simplex virus type 1 (R130)
Sponsor: Shanghai Yunying Medical Technology
Collaborators: The PLA Navy Anqing Hospital